ROCKVILLE, MD – October 3, 2023 – DP Clinical congratulates NervGen Pharma Corp., a biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, on dosing its first subject in the Company’s landmark Phase 1b/2a clinical trial for its proprietary lead compound, NVG-291, in individuals with spinal cord injury (SCI). Read more at [...]
ROCKVILLE, MD - September 28, 2023 - MediWound Ltd., an Israeli biopharmaceutical company, announced the US commercial availability of NexoBrid® in adults with severe thermal burns – a first step in the product becoming the new standard of care for eschar removal. MediWound has partnered with DP Clinical, a full-service CRO located in Rockville, Maryland, [...]
ROCKVILLE, MD – December 13, 2022 – Isa McClure, Clinical Project Manager and James (Jim) Hamer, Director, Spinal Cord Injury (SCI) programs will be moderating a breakout session at the upcoming American Spinal Injury Association (ASIA) April 17 - 19, 2023. DP Clinical is a proud partner of ASIA who, in 2023, celebrates 50 years of work [...]
ROCKVILLE, MD – October 26, 2022 – James (Jim) Hamer, Director, Spinal Cord Injury (SCI) Programs was recently recognized by the Canadian Government for his work with the Strategic Science Fund (SSF). Jim served as a Technical Reviewer for the country's new SSF program. This program was implemented to improve the effectiveness of federal investments used to [...]
ROCKVILLE, MD – June 10, 2021 – DP Clinical, Inc., a Contract Research Organization (CRO) specializing in dermatology, infectious disease, neuroscience, oncology, and ophthalmology Phase I-III clinical programs; continues its growth with the addition of Tim Urschel as Vice President, Regulatory Affairs/Quality Assurance. Mr. Urschel joined the DP Clinical team in October 2020 and brings [...]
ROCKVILLE, MD – February 19, 2021 – DP Clinical, Inc., a privately held Contract Research Organization (CRO), announced the database lock of its first COVID-19 clinical trial. Taking place the United States, the goal of the study was to determine a suitable dosage of a drug candidate for the treatment of severe acute respiratory syndrome-related [...]
ROCKVILLE, MD – February 16, 2021 – DP Clinical, Inc., a Contract Research Organization (CRO) located in Rockville, Maryland, announces James (Jim) Hamer, Director, Spinal Cord Injury (SCI) Programs, at DP Clinical has been elected to the Board of Directors for Unite 2 Fight Paralysis (U2FP) organization and will serve a three-year term. U2FP’s mission [...]
As a Rockville, Maryland-based company, DP Clinical has joined forces with other companies throughout the state to show support and unity as we work together to combat the COVID-19 pandemic. We have joined with the Maryland Tech Council to spread the word - “We come together in adversity. We put our heads down to solve [...]
ROCKVILLE, MD – September 18, 2019 – DP Clinical, Inc., a Contract Research Organization (CRO) specializing in infectious disease, neuroscience, oncology, and ophthalmology Phase I-III clinical programs; congratulates ADMA Biologics’ on the approval of ASCENIV™ (immune globulin intravenous, human – slra 10% liquid). DP Clinical provided a full complement of CRO services for ADMA Biologics [...]
REDWOOD CITY, Calif., Aug. 12, 2019 /PRNewswire/ -- DP Clinical, Inc. and Comprehend Systems, Inc. are joining forces to transition the Rockville, Maryland-based CRO from spreadsheets and EDC reports to a system that aligns study teams with visual data analytics, automated KRI monitoring with alerts, and fully-auditable task management workflow. Click here to read more.